Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
<p>Abstract</p> <p>Background</p> <p>We previously reported an HLA-A24-restricted cytotoxic T-cell epitope, Survivin-2B80-88, derived from a splice variant of survivin, survivin-2B. In this report, we show a novel HLA-A24-restricted T-cell epitope, Survivin-C58, derived...
Main Authors: | Yamaguchi Akira, Miyazaki Akihiro, Idenoue Satomi, Hirohashi Yoshihiko, Torigoe Toshihiko, Kobayashi Jun-ichi, Hiratsuka Hiroyoshi, Sato Noriyuki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/7/1/1 |
Similar Items
-
A role for Survivin splice variant heterodimerisation in regulating Survivin function
by: Tate, Sharon Amber
Published: (2006) -
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
by: Honsey Laura E, et al.
Published: (2005-03-01) -
The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival
by: Anna G. Antonacopoulou, et al.
Published: (2010-01-01) -
The Roles of Survivin and its Spliced Isoforms in Hepatocellular Carcinoma
by: Hsin-Yi Tseng, et al.
Published: (2010) -
Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer
by: Minamida Hidetoshi, et al.
Published: (2004-06-01)